Winners of 2022 Biomedical Innovation Program awards address significant clinical problems

BIP awardeees Gregory Landry, Yali Jia, Martin Pike

Projects aim to provide novel improvements to screening for diabetic retinopathy, optimizing prosthetic fit via smartphone, and imaging metabolic activity.

Three projects have been named recipients of 2022 Biomedical Innovation Program funding in the Device, Diagnostic, and Software track. The projects are led by Yali Jia, Ph.D., FAIMBE, Gregory Landry, M.D., and Martin Pike, Ph.D.

BIP awards provide funds, project management and mentorship to facilitate the development of innovative technologies at OHSU. The awards help move innovations for improving health and well-being to the marketplace and the patient.

Awarded projects

  • Yali Jia, Ph.D., FAIMBE, associate professor of ophthalmology & biomedical engineering, Jennie P. Weeks Professor of Ophthalmology, associate director of Center for Ophthalmic Optics & Lasers, Casey Eye Institute
    COOL-ART-DR, a comprehensive diabetic retinopathy reading platform based on optical coherence tomography angiography
  • Gregory Landry, M.D., professor and chief of vascular surgery, Department of Surgery, OHSU School of Medicine
    Smart Socket: A novel and dynamic microprocessor-controlled pneumatic socket that optimizes prosthetic fit via a smartphone application
  • Martin Pike, Ph.D., associate professor, Advanced Imaging Research Center
    Development of Activity MRI (aMRI): Direct comparison to PET

See the abstracts for all BIP awarded projects.

Biomedical Innovation Program

The BIP is a collaboration of the Oregon Clinical & Translational Research Institute (OCTRI), OHSU Technology Transfer, and OHSU Collaborations & Entrepreneurship. Detailed information on the program is available on the OCTRI BIP page. For information on OCTRI’s other research support services, visit

Additional funding for the program is made possible by OHSU Innovation & Research, and the University Venture Development Fund (UVDF). Interested donors are encouraged to email Timothy Coffey ( at the OHSU Foundation.

OCTRI is supported by (UL1TR002369) from the National Center for Advancing Translational Science (NCATS) at the National Institutes of Health (NIH).